Ritobegron Completed Phase 2 Trials for Overactive Bladder Syndrome (OABS) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00742833A Phase II Study of KUC-7483 in Patients With Overactive Bladder